Perspective

The case for an evidence-based reference interval for serum magnesium: The time has come

Rebecca B. Costello, Ronald J. Elin, Andrea Rosanoff, Taylor C. Wallace, Fernando Guerrero-Romero, Adela Hruby, Pamela L. Lutsey, Forrest H. Nielsen, Martha Rodriguez-Moran, Yiqing Song, Linda V. Van Horn

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The 2015 Dietary Guidelines Advisory Committee indicated that magnesium was a shortfall nutrient that was underconsumed relative to the Estimated Average Requirement (EAR) for many Americans. Approximately 50% of Americans consume less than the EAR for magnesium, and some age groups consume substantially less. A growing body of literature from animal, epidemiologic, and clinical studies has demonstrated a varied pathologic role for magnesium deficiency that includes electrolyte, neurologic, musculoskeletal, and inflammatory disorders; osteoporosis; hypertension; cardiovascular diseases; metabolic syndrome; and diabetes. Studies have also demonstrated that magnesium deficiency is associated with several chronic diseases and that a reduced risk of these diseases is observed with higher magnesium intake or supplementation. Subclinical magnesium deficiency can exist despite the presentation of a normal status as defined within the current serum magnesium reference interval of 0.75-0.95 mmol/L. This reference interval was derived from data from NHANES I (1974), which was based on the distribution of serum magnesium in a normal population rather than clinical outcomes. What is needed is an evidenced-based serum magnesium reference interval that reflects optimal health and the current food environment and population. We present herein data from an array of scientific studies to support the perspective that subclinical deficiencies in magnesium exist, that they contribute to several chronic diseases, and that adopting a revised serum magnesium reference interval would improve clinical care and public health.

Original languageEnglish (US)
Pages (from-to)977-993
Number of pages17
JournalAdvances in Nutrition
Volume7
Issue number6
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Magnesium
magnesium
Magnesium Deficiency
Serum
Estimated Average Requirement
Chronic Disease
Food
Nutrition Policy
chronic diseases
Nutrition Surveys
Advisory Committees
Nervous System
Electrolytes
Population
Osteoporosis
Epidemiologic Studies
Cardiovascular Diseases
Dietary Guidelines
National Health and Nutrition Examination Survey
Public Health

Keywords

  • Chronic disease
  • Magnesium deficiency
  • Plasma magnesium
  • Reference interval
  • Serum magnesium

ASJC Scopus subject areas

  • Food Science
  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Costello, R. B., Elin, R. J., Rosanoff, A., Wallace, T. C., Guerrero-Romero, F., Hruby, A., ... Van Horn, L. V. (2016). Perspective: The case for an evidence-based reference interval for serum magnesium: The time has come. Advances in Nutrition, 7(6), 977-993. https://doi.org/10.3945/an.116.012765

Perspective : The case for an evidence-based reference interval for serum magnesium: The time has come. / Costello, Rebecca B.; Elin, Ronald J.; Rosanoff, Andrea; Wallace, Taylor C.; Guerrero-Romero, Fernando; Hruby, Adela; Lutsey, Pamela L.; Nielsen, Forrest H.; Rodriguez-Moran, Martha; Song, Yiqing; Van Horn, Linda V.

In: Advances in Nutrition, Vol. 7, No. 6, 01.01.2016, p. 977-993.

Research output: Contribution to journalArticle

Costello, RB, Elin, RJ, Rosanoff, A, Wallace, TC, Guerrero-Romero, F, Hruby, A, Lutsey, PL, Nielsen, FH, Rodriguez-Moran, M, Song, Y & Van Horn, LV 2016, 'Perspective: The case for an evidence-based reference interval for serum magnesium: The time has come', Advances in Nutrition, vol. 7, no. 6, pp. 977-993. https://doi.org/10.3945/an.116.012765
Costello RB, Elin RJ, Rosanoff A, Wallace TC, Guerrero-Romero F, Hruby A et al. Perspective: The case for an evidence-based reference interval for serum magnesium: The time has come. Advances in Nutrition. 2016 Jan 1;7(6):977-993. https://doi.org/10.3945/an.116.012765
Costello, Rebecca B. ; Elin, Ronald J. ; Rosanoff, Andrea ; Wallace, Taylor C. ; Guerrero-Romero, Fernando ; Hruby, Adela ; Lutsey, Pamela L. ; Nielsen, Forrest H. ; Rodriguez-Moran, Martha ; Song, Yiqing ; Van Horn, Linda V. / Perspective : The case for an evidence-based reference interval for serum magnesium: The time has come. In: Advances in Nutrition. 2016 ; Vol. 7, No. 6. pp. 977-993.
@article{875a4b1e03b445c9bd79f8d4dbff6a6e,
title = "Perspective: The case for an evidence-based reference interval for serum magnesium: The time has come",
abstract = "The 2015 Dietary Guidelines Advisory Committee indicated that magnesium was a shortfall nutrient that was underconsumed relative to the Estimated Average Requirement (EAR) for many Americans. Approximately 50{\%} of Americans consume less than the EAR for magnesium, and some age groups consume substantially less. A growing body of literature from animal, epidemiologic, and clinical studies has demonstrated a varied pathologic role for magnesium deficiency that includes electrolyte, neurologic, musculoskeletal, and inflammatory disorders; osteoporosis; hypertension; cardiovascular diseases; metabolic syndrome; and diabetes. Studies have also demonstrated that magnesium deficiency is associated with several chronic diseases and that a reduced risk of these diseases is observed with higher magnesium intake or supplementation. Subclinical magnesium deficiency can exist despite the presentation of a normal status as defined within the current serum magnesium reference interval of 0.75-0.95 mmol/L. This reference interval was derived from data from NHANES I (1974), which was based on the distribution of serum magnesium in a normal population rather than clinical outcomes. What is needed is an evidenced-based serum magnesium reference interval that reflects optimal health and the current food environment and population. We present herein data from an array of scientific studies to support the perspective that subclinical deficiencies in magnesium exist, that they contribute to several chronic diseases, and that adopting a revised serum magnesium reference interval would improve clinical care and public health.",
keywords = "Chronic disease, Magnesium deficiency, Plasma magnesium, Reference interval, Serum magnesium",
author = "Costello, {Rebecca B.} and Elin, {Ronald J.} and Andrea Rosanoff and Wallace, {Taylor C.} and Fernando Guerrero-Romero and Adela Hruby and Lutsey, {Pamela L.} and Nielsen, {Forrest H.} and Martha Rodriguez-Moran and Yiqing Song and {Van Horn}, {Linda V.}",
year = "2016",
month = "1",
day = "1",
doi = "10.3945/an.116.012765",
language = "English (US)",
volume = "7",
pages = "977--993",
journal = "Advances in nutrition (Bethesda, Md.)",
issn = "2161-8313",
publisher = "American Society for Nutrition",
number = "6",

}

TY - JOUR

T1 - Perspective

T2 - The case for an evidence-based reference interval for serum magnesium: The time has come

AU - Costello, Rebecca B.

AU - Elin, Ronald J.

AU - Rosanoff, Andrea

AU - Wallace, Taylor C.

AU - Guerrero-Romero, Fernando

AU - Hruby, Adela

AU - Lutsey, Pamela L.

AU - Nielsen, Forrest H.

AU - Rodriguez-Moran, Martha

AU - Song, Yiqing

AU - Van Horn, Linda V.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The 2015 Dietary Guidelines Advisory Committee indicated that magnesium was a shortfall nutrient that was underconsumed relative to the Estimated Average Requirement (EAR) for many Americans. Approximately 50% of Americans consume less than the EAR for magnesium, and some age groups consume substantially less. A growing body of literature from animal, epidemiologic, and clinical studies has demonstrated a varied pathologic role for magnesium deficiency that includes electrolyte, neurologic, musculoskeletal, and inflammatory disorders; osteoporosis; hypertension; cardiovascular diseases; metabolic syndrome; and diabetes. Studies have also demonstrated that magnesium deficiency is associated with several chronic diseases and that a reduced risk of these diseases is observed with higher magnesium intake or supplementation. Subclinical magnesium deficiency can exist despite the presentation of a normal status as defined within the current serum magnesium reference interval of 0.75-0.95 mmol/L. This reference interval was derived from data from NHANES I (1974), which was based on the distribution of serum magnesium in a normal population rather than clinical outcomes. What is needed is an evidenced-based serum magnesium reference interval that reflects optimal health and the current food environment and population. We present herein data from an array of scientific studies to support the perspective that subclinical deficiencies in magnesium exist, that they contribute to several chronic diseases, and that adopting a revised serum magnesium reference interval would improve clinical care and public health.

AB - The 2015 Dietary Guidelines Advisory Committee indicated that magnesium was a shortfall nutrient that was underconsumed relative to the Estimated Average Requirement (EAR) for many Americans. Approximately 50% of Americans consume less than the EAR for magnesium, and some age groups consume substantially less. A growing body of literature from animal, epidemiologic, and clinical studies has demonstrated a varied pathologic role for magnesium deficiency that includes electrolyte, neurologic, musculoskeletal, and inflammatory disorders; osteoporosis; hypertension; cardiovascular diseases; metabolic syndrome; and diabetes. Studies have also demonstrated that magnesium deficiency is associated with several chronic diseases and that a reduced risk of these diseases is observed with higher magnesium intake or supplementation. Subclinical magnesium deficiency can exist despite the presentation of a normal status as defined within the current serum magnesium reference interval of 0.75-0.95 mmol/L. This reference interval was derived from data from NHANES I (1974), which was based on the distribution of serum magnesium in a normal population rather than clinical outcomes. What is needed is an evidenced-based serum magnesium reference interval that reflects optimal health and the current food environment and population. We present herein data from an array of scientific studies to support the perspective that subclinical deficiencies in magnesium exist, that they contribute to several chronic diseases, and that adopting a revised serum magnesium reference interval would improve clinical care and public health.

KW - Chronic disease

KW - Magnesium deficiency

KW - Plasma magnesium

KW - Reference interval

KW - Serum magnesium

UR - http://www.scopus.com/inward/record.url?scp=84997207644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997207644&partnerID=8YFLogxK

U2 - 10.3945/an.116.012765

DO - 10.3945/an.116.012765

M3 - Article

VL - 7

SP - 977

EP - 993

JO - Advances in nutrition (Bethesda, Md.)

JF - Advances in nutrition (Bethesda, Md.)

SN - 2161-8313

IS - 6

ER -